Avenge Bio, a cell therapy biotech from Rice, is closed
Cell therapy startup Avenge Bio has shut down, Endpoints News has learned.
The company ceased all operations and sold its lead asset, Xontogeny CEO Chris …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
